Skip to content
Contact Us
Webinar - On Demand

Generating Clinically Actionable Tissue Biomarker Data in Complex Diseases: Spotlight on Immuno-Oncology and Dermatology

Date: November 1, 2022

Duration: 45 Minutes

Understanding the mechanism of action or proof of concept following drug treatment may require a detailed analysis of what is happening within tissues.
 
Multiplex immunofluorescence is a useful approach for generating detailed information on tissues through immunophenotyping and spatial analysis pre- and post-treatment. While often applied in the immune-oncology field, this approach is also useful in autoimmune diseases and dermatology, where it is possible to source clinical biopsies more routinely.
 
This webinar takes a deeper dive into these complex diseases and covers important points to consider for the successful development and use of tissue-based biomarker assays.


Topics covered:

  • Approaches for tissue-based interrogation of protein biomarkers
     
  • Clinically actionable data - considerations for assay type and level of validation required
     
  • How to maximize the utility of clinical samples
     
  • Examples from immuno-oncology and dermatology

Register to Watch Webinar On Demand
Speakers

Amanda Woodroofe

Amanda Woodrooffe PhD
Precision for Medicine

Experienced leader of scientific operations for drug discovery in both the pharmaceutical and CRO industries. Driven to provide actionable data enabling biopharmaceutical research and development. Collaborative partner ensuring licensing and scientific support for corporate development initiatives.

Darren Davis

Darren PhD
Precision for Medicine

Visionary leader with decades of distinguished biotechnology and clinical translational research experience. Founded ApoCell in 2004 and later was instrumental in developing and commercializing the ApoStream® rare-cell liquid biopsy technology. Globally recognized cancer researcher and the author of more than 100 peer-reviewed publications. Dedicated and committed to improving the lives of patients with debilitating diseases.